| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
St George's Hospital Medical School, London, UK
CORRESPONDENCE: P.W. Jones, St George's Hospital Medical School, London, SW17 0RE, UK. Fax: 44 2087255955. E-mail: pjones@sghms.ac.uk
Keywords: airflow obstruction, asthma, chronic obstructive pulmonary disease, quality of life, respiratory rehabilitation
Received: July 13, 2000
Accepted August 6, 2001
Health status (or Health-Related Quality of Life) measurement is an established method for assessing the overall efficacy of treatments for asthma and chronic obstructive pulmonary disease (COPD). Such measurements can indicate the potential clinical significance of a treatment's effect.
This paper is concerned with methods of estimating the threshold of clinical significance for three widely used health status questionnaires for asthma and COPD: the Asthma Quality of Life Questionnaire, Chronic Respiratory Questionnaire and St George's Respiratory Questionnaire. It discusses the methodology used to obtain such estimates and shows that the estimates appear to be fairly reliable; i.e. for a given questionnaire, similar estimates may be obtained in different studies.
These empirically derived thresholds are all mean estimates with confidence intervals around them. The presence of these confidence intervals affects the way in which the thresholds may be used to draw inferences concerning the clinical relevance of clinical trial results. A new system of judging the magnitude of clinically significant results is proposed.
Finally, an attempt is made to translate these thresholds into scenarios that illustrate what a clinically significant change with treatment may mean to an individual patient.
This article has been cited by other articles:
|
|
 |
|
  S J Singh, P W Jones, R Evans, and M D L Morgan Minimum clinically important improvement for the incremental shuttle walking test Thorax, September 1, 2008; 63(9): 775 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Albert and P. M. A. Calverley Drugs (including oxygen) in severe COPD Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Ries, B. J. Make, and J. J. Reilly Pulmonary Rehabilitation in Emphysema Proceedings of the ATS, May 1, 2008; 5(4): 524 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Cote, V. Pinto-Plata, K. Kasprzyk, L. J. Dordelly, and B. R. Celli The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD Chest, December 1, 2007; 132(6): 1778 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Skumlien, E A Skogedal, O Bjortuft, and M S Ryg Four weeks' intensive rehabilitation generates significant health effects in COPD patients Chronic Respiratory Disease, February 1, 2007; 4(1): 5 - 13. [Abstract] [PDF]
|
|
|
|
|
|
S Taylor, S Eldridge, Y-M Chang, R Sohanpal, and A Clarke Evaluating hospital at home and early discharge schemes for patients with an acute exacerbation of COPD Chronic Respiratory Disease, February 1, 2007; 4(1): 33 - 43. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Kardos, M. Wencker, T. Glaab, and C. Vogelmeier Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Wood, R. J. McKenna Jr, R. D. Yusen, D. H. Sterman, D. E. Ost, S. C. Springmeyer, H. X. Gonzalez, M. S. Mulligan, T. Gildea, W. V. Houck, et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 65 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Bateman, J. Bousquet, M. L. Keech, W. W. Busse, T. J. H. Clark, S. E. Pedersen, and on behalf of the GOAL Investigators Group The correlation between asthma control and health status: the GOAL study Eur. Respir. J., January 1, 2007; 29(1): 56 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Larson, K. Ahijevych, A. Gift, L. Hoffman, S. L. Janson, D. M. Lanuza, N. K. Leidy, P. Meek, J. Roberts, T. Weaver, et al. American thoracic society statement on research priorities in respiratory nursing. Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 471 - 478. [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Naunheim, D. E. Wood, Z. Mohsenifar, A. L. Sternberg, G. J. Criner, M. M. DeCamp, C. C. Deschamps, F. J. Martinez, F. C. Sciurba, J. Tonascia, et al. Long-Term Follow-Up of Patients Receiving Lung-Volume-Reduction Surgery Versus Medical Therapy for Severe Emphysema by the National Emphysema Treatment Trial Research Group Ann. Thorac. Surg., August 1, 2006; 82(2): 431 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Nici, C. Donner, E. Wouters, R. Zuwallack, N. Ambrosino, J. Bourbeau, M. Carone, B. Celli, M. Engelen, B. Fahy, et al. American thoracic society/european respiratory society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1390 - 1413. [Full Text] [PDF]
|
|
|
|
|
|
P. W. Jones and A. G. N. Agusti Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J., April 1, 2006; 27(4): 822 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Goldstein Rehabilitation and the National Emphysema Treatment Trial Chest, December 1, 2005; 128(6): 3783 - 3784. [Full Text] [PDF]
|
|
|
|
|
|
A. L. Ries, B. J. Make, S. M. Lee, M. J. Krasna, M. Bartels, R. Crouch, A. P. Fishman, and for the National Emphysema Treatment Trial Researc The Effects of Pulmonary Rehabilitation in the National Emphysema Treatment Trial Chest, December 1, 2005; 128(6): 3799 - 3809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hillerdal, C.-G. Lofdahl, K. Strom, B.-E. Skoogh, L. Jorfeldt, F. Nilsson, D. Forslund-Stiby, J. Ranstam, E. Gyllstedt, and of the Swedish VOLREM Group Comparison of Lung Volume Reduction Surgery and Physical Training on Health Status and Physiologic Outcomes: A Randomized Controlled Clinical Trial Chest, November 1, 2005; 128(5): 3489 - 3499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38. [Full Text] [PDF]
|
|
|
|
|
|
M. Needham and R. A. Stockley Exacerbations in {alpha}1-antitrypsin deficiency Eur. Respir. J., June 1, 2005; 25(6): 992 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E F M Wouters, D S Postma, B Fokkens, W C J Hop, J Prins, A F Kuipers, H R Pasma, C A J Hensing, E C Creutzberg, and for the COSMIC (COPD and Seretide: a Multi-Center Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial Thorax, June 1, 2005; 60(6): 480 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alvarez-Mon, M. Miravitlles, J. Morera, L. Callol, and J. L. Alvarez-Sala Treatment With the Immunomodulator AM3 Improves the Health-Related Quality of Life of Patients With COPD Chest, April 1, 2005; 127(4): 1212 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Gross Tiotropium Bromide Chest, December 1, 2004; 126(6): 1946 - 1953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Jones Clinical Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 167 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z J McKeough,, J A Alison, M S Bayfield, and P. Bye Reduction in resting energy expenditure following lung volume reduction surgery in subjects with chronic obstructive pulmonary disease Chronic Respiratory Disease, October 1, 2004; 1(4): 197 - 202. [Abstract] [PDF]
|
|
|
|
|
|
S. Spencer, P.M.A. Calverley, P.S. Burge, and P.W. Jones Impact of preventing exacerbations on deterioration of health status in COPD Eur. Respir. J., May 1, 2004; 23(5): 698 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Miravitlles, M Ferrer, A Pont, R Zalacain, J L Alvarez-Sala, F Masa, H Verea, C Murio, F Ros, and R Vidal Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study Thorax, May 1, 2004; 59(5): 387 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.B. Oostenbrink, M.P.M.H. Rutten-van Molken, M.J. Al, J.A. Van Noord, and W. Vincken One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2004; 23(2): 241 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Tashkin and C. B. Cooper The Role of Long-Acting Bronchodilators in the Management of Stable COPD Chest, January 1, 2004; 125(1): 249 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.M. Calverley, W. Boonsawat, Z. Cseke, N. Zhong, S. Peterson, and H. Olsson Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease Eur. Respir. J., December 1, 2003; 22(6): 912 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Stolk, W H Ng, M E Bakker, J H C Reiber, K F Rabe, H Putter, and B C Stoel Correlation between annual change in health status and computer tomography derived lung density in subjects with {alpha}1-antitrypsin deficiency Thorax, December 1, 2003; 58(12): 1027 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Sin, F. A. McAlister, S. F. P. Man, and N. R. Anthonisen Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review JAMA, November 5, 2003; 290(17): 2301 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Monninkhof, P. van der Valk, J. van der Palen, C. van Herwaarden, and G. Zielhuis Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease Eur. Respir. J., November 1, 2003; 22(5): 815 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P M A Calverley Closing the NETT on lung volume reduction surgery Thorax, August 1, 2003; 58(8): 651 - 653. [Full Text]
|
|
|
|
|
|
S Spencer and P W Jones Time course of recovery of health status following an infective exacerbation of chronic bronchitis Thorax, July 1, 2003; 58(7): 589 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.W. Jones and R.M. Kaplan Methodological issues in evaluating measures of health as outcomes for COPD Eur. Respir. J., June 1, 2003; 21(41_suppl): 13S - 18s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.R. Curtis and D.L. Patrick The assessment of health status among patients with COPD Eur. Respir. J., June 1, 2003; 21(41_suppl): 36S - 45s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 National Emphysema Treatment Trial Research Group A Randomized Trial Comparing Lung-Volume-Reduction Surgery with Medical Therapy for Severe Emphysema N. Engl. J. Med., May 22, 2003; 348(21): 2059 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.J. Witek Jr and D.A. Mahler Minimal important difference of the transition dyspnoea index in a multinational clinical trial Eur. Respir. J., February 1, 2003; 21(2): 267 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hajiro and K. Nishimura Minimal clinically significant difference in health status: the thorny path of health status measures? Eur. Respir. J., March 1, 2002; 19(3): 390 - 391. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
